Product Description: Apomorphine ((-)-Apomorphine) hydrochloride is an orally active agonist of Dopamine receptor. Apomorphine hydrochloride can be used in study Parkinson, biphasic dyskinesias, urinary dysfunction, dystonia, dyspnoea, anismus and belching[1][2].
Formula: C17H18ClNO2
Citations: Sci Rep. 2019 Jan 22;9(1):254. /Andrologia. 2019 Feb;51(1):e13160./Andrology. 2022 Mar 2./Asian J Androl. 2018 Sep-Oct;20(5):448-453./J Sex Med. 2018 Feb;15(2):136-147. /Oxid Med Cell Longev. 2018 Jun 26;2018:2917981. /Funct Integr Genomics. 2024 Sep 17;24(5):161.
References: [1]Frankel JP, et al. Subcutaneous apomorphine in the treatment of Parkinson's disease. J Neurol Neurosurg Psychiatry. 1990 Feb;53(2):96-101./[2]Carbone F, et al. Apomorphine for Parkinson's Disease: Efficacy and Safety of Current and New Formulations. CNS Drugs. 2019 Sep;33(9):905-918.
CAS Number: 314-19-2
Molecular Weight: 303.78
Research Area: Neurological Disease
Target: 5-HT Receptor;Dopamine Receptor
Deutsch
English
